Drug
Intervention1 Fxb0871
Intervention1 Fxb0871: highest development phase Phase 1, developed by Shanghai Fosun Pharmaceutical. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Shanghai Fosun Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| Intervention1：FXB0871 NCT07558200 | Phase 1 | Solid Tumors |
Latest
No recent events.
Follow Intervention1 Fxb0871 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.